Japanese Biotech Stocks

Takeda Pharmaceutical

Market Cap: JP¥9.2t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

Otsuka Holdings

Market Cap: JP¥5.5t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Daiichi Sankyo Company

Market Cap: JP¥5.5t

Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.

Astellas Pharma

Market Cap: JP¥4.5t

Manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally.

Shionogi

Market Cap: JP¥3.1t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

Kyowa Kirin

Market Cap: JP¥1.5t

Engages in the research, development, manufacture, import/export, and market of pharmaceuticals products worldwide.

Eisai

Market Cap: JP¥1.4t

Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals.

Ono Pharmaceutical

Market Cap: JP¥1.2t

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Sumitomo Pharma

Market Cap: JP¥890.3b

Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.

Santen Pharmaceutical

Market Cap: JP¥554.6b

Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

Hisamitsu Pharmaceutical

Market Cap: JP¥422.5b

Manufactures and sells pharmaceuticals in Japan.

Nippon Shinyaku

Market Cap: JP¥336.7b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

Tsumura

Market Cap: JP¥307.1b

Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.

Sawai Group Holdings

Market Cap: JP¥269.7b

Together with subsidiaries, engages in the research and development, manufacture, and marketing of generic pharmaceuticals.

Towa Pharmaceutical

Market Cap: JP¥214.1b

Manufactures and sale ethical drugs in Japan.

Kissei Pharmaceutical

Market Cap: JP¥201.7b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.

PeptiDream

Market Cap: JP¥173.3b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

GNI Group

Market Cap: JP¥160.1b

Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.

Takara Bio

Market Cap: JP¥138.2b

Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.

KYORIN Pharmaceutical

Market Cap: JP¥98.2b

Through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally.

Zeria Pharmaceutical

Market Cap: JP¥97.3b

Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally.

Nxera Pharma

Market Cap: JP¥82.3b

Operates as a biopharmaceutical company, engages in drug discovery and development in Japan, the United States, Germany, Switzerland, Bermuda, the United Kingdom, and internationally.

ASKA Pharmaceutical HoldingsLtd

Market Cap: JP¥69.9b

Through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan.

Shin Nippon Biomedical Laboratories

Market Cap: JP¥69.3b

A contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally.

3-D Matrix

Market Cap: JP¥68.0b

3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally.

Daito PharmaceuticalLtd

Market Cap: JP¥42.6b

Engages in the manufacture and sale of pharmaceutical products in Japan and internationally.

Seikagaku

Market Cap: JP¥40.0b

Manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.

Japan Tissue Engineering

Market Cap: JP¥27.6b

Engages in the regenerative medicine business in Japan.

Fuso Pharmaceutical IndustriesLtd

Market Cap: JP¥20.7b

Manufactures and sells pharmaceuticals and medical equipment in Japan.

Astena Holdings

Market Cap: JP¥20.3b

Manufactures and sells medicine-related products in Japan.

StemRIM

Market Cap: JP¥18.2b

A biotechnology company, researches and develops regeneration-inducing medicine in Japan and internationally.

Pharma Foods International

Market Cap: JP¥18.0b

Engages in the development and sale of functional food ingredients in Japan.

ReproCELL

Market Cap: JP¥16.1b

Provides stem cell research and drug discovery services in Japan.

Kidswell Bio

Market Cap: JP¥12.4b

Develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan.

CellSource

Market Cap: JP¥8.1b

Engages in the regenerative medicine-related businesses in Japan.

Chordia Therapeutics

Market Cap: JP¥8.0b

A biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan.